Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma.
about
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsAddition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and childrenAddition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthmaAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and childrenRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsCombination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthmaLong-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthmaAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adultsImpact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment optionsOnset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthmaA retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma.Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs.Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction.Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice.Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
P2860
Q24202005-138B06CE-56FB-4316-B2F8-95E0798E95E2Q24235303-FA713994-52BC-4F89-9E8C-2AD1C67739D6Q24235964-9E01CED0-4685-4AC7-8E94-B19435F0A1C7Q24240464-CA08A56D-11B7-4EA9-80B8-D576EED571AFQ24241453-6F407721-BC47-4E63-BCF8-BCAAF6F4ED81Q24245383-2C151F2E-A4DF-4C96-8250-E111D1CE5DF3Q24245643-FB01E0BC-C57D-4FB2-8C50-03D774AF9D4AQ24245719-EB7AC28C-793B-47B2-93C8-FAC451BA0E92Q26826860-B8513048-1E7B-4739-84EC-37FE4C17A6F8Q33644839-82FECF55-2590-483D-AEA3-C06DCFC3A2ACQ34573003-0962F373-8C77-4B59-948E-1D725ECC4544Q36326508-86DD6899-51DD-47E1-858B-DA5F05F92D46Q36432119-F07E2536-E875-4803-AF2A-7E475EFF659BQ37187443-DD541AD8-DBB0-4451-9A6C-F9A7517298E8Q37334374-8A370891-31AD-41B7-A343-6724FD9E8539Q37800043-763AAB7E-580C-4C09-8627-62AA1E127C30Q38043452-4FF8B3D5-A66F-4F1C-B228-66842AEF22D6Q38707759-2397FFE4-7505-47C8-9E13-4B6A6A3F9C5FQ38759118-BF617D74-5A70-4BB8-9437-364717D8081CQ42629467-BD72B36C-E28C-46DF-92D9-DCB256447CE5Q46384533-68A776F8-4C8B-467E-AB27-5E249FEBAB93Q47152651-937290C3-07B7-4B22-9702-58A0F4B7339DQ48496612-3468FDFB-2BEF-4B86-8029-92EB00B2DF26Q50915470-9839F96F-9A6F-4EC5-8573-2E70F2D12EE6Q51170291-04CAF652-10A2-4A47-B192-6BB6299232DE
P2860
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Combination therapy with singl ...... th moderate persistent asthma.
@en
Combination therapy with singl ...... th moderate persistent asthma.
@nl
type
label
Combination therapy with singl ...... th moderate persistent asthma.
@en
Combination therapy with singl ...... th moderate persistent asthma.
@nl
prefLabel
Combination therapy with singl ...... th moderate persistent asthma.
@en
Combination therapy with singl ...... th moderate persistent asthma.
@nl
P2093
P2860
P356
P1476
Combination therapy with singl ...... th moderate persistent asthma.
@en
P2093
Avraham Eliraz
Eric D Bateman
Maria João Gomes
Michael G Toumbis
Rudolf M Huber
Theo A Bantje
P2860
P2888
P304
P356
10.1007/BF03256655
P577
2003-01-01T00:00:00Z